<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00467571</url>
  </required_header>
  <id_info>
    <org_study_id>ID11-48-20</org_study_id>
    <nct_id>NCT00467571</nct_id>
  </id_info>
  <brief_title>Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura</brief_title>
  <official_title>Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous studies suggest that chronic idiopathic thrombocytopenic purpura is associated with
      Helicobacter pylori infection. The objective is to study the effect of Helicobacter pylori
      eradication on platelet count.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children with chronic idiopathic thrombocytopenic purpura who have Helicobacter pylori
      infection are enrolled. Helicobacter pylori infection is diagnosed by urea breath test.
      Patients who have Helicobacter pylori infection will be randomized into 2 groups: control and
      treatment groups. The treatment group will receive 2 antibiotics and proton-pump inhibitors
      for 14 days for eradication of infection. Repeated urea breath test at week 6-8 after
      treatment. Blood tests for platelet count will be performed every month for 6 months in both
      groups. Platelet count at 6 months in both group will be compared.Blood for platelet antibody
      will be performed at 3 and 6 months. Control group will receive treatment for Helicobacter
      pylori at the end of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>platelet count</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>platelet antibody after treatment of Helicobacter pylori infection, compared with control group (no treatment of Helicobacter pylori)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>platelet count</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Chronic Idiopathic Thrombocytopenic Purpura</condition>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: lansoprazole, clarithromycin, amoxycillin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lansoprazole, clarithromycin, amoxycillin</intervention_name>
    <description>lansoprazole (15, 30 mg) 1 tab twice daily, clarithromycin 7.5 mg/kg twice daily, amoxycillin 25 mg/kg twice daily; rout: orally; duration 14 days</description>
    <arm_group_label>I</arm_group_label>
    <other_name>lansoprazole or Prevacid</other_name>
    <other_name>clarithromycin or Klacid</other_name>
    <other_name>Amoxycillin or Ibiamox</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children who was diagnosed as chronic ITP, defined by platelets below 100,000/uL for
             more than 6 months without identified causes.

          -  13C-urea breath test (UBT) was performed for diagnosis of Helicobacter pylori
             infection.

        Exclusion Criteria:

          -  Patients who had a previous treatment for H. pylori infection.

               -  Patients require prednisolone more than 0.5 mg/kg/day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suporn Treepongkaruna, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Ramathibodi Hospital, Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Ramathibodi Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2007</study_first_submitted>
  <study_first_submitted_qc>April 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2007</study_first_posted>
  <last_update_submitted>May 1, 2013</last_update_submitted>
  <last_update_submitted_qc>May 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic idiopathic thrombocytopenic purpura</keyword>
  <keyword>Helicobacter pylori infection</keyword>
  <keyword>platelet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Purpura</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic, Idiopathic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clarithromycin</mesh_term>
    <mesh_term>Lansoprazole</mesh_term>
    <mesh_term>Dexlansoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

